FDA Import Refusal 799-1509852-9/11/1 — Astra Zeneca Pharmaceuticals Inc
The FDA refused shipment 799-1509852-9/11/1 from Astra Zeneca Pharmaceuticals Inc (Philippines) on Nov 9, 2022. The refused product falls under Drugs and Biologics — DAPAGLIFLOZIN (ANTI-DIABETIC). Cited charge: 75 This firm has 2 other import refusals on record.
Refusal details
- Date
- Nov 9, 2022
- Country
- Philippines
- Product Category
- Drugs and Biologics
- Product Code
- 61PCB70 DAPAGLIFLOZIN (ANTI-DIABETIC)
- Charges
- 75